Dental Caries Treatment Market size is poised to exhibit a considerable growth trajectory between 2023-2032 led by growing oral health problems across the globe.
The prevalence of dental caries and tooth decay has surged over the last decade due to poor oral hygiene, improper brushing, and gingival or gum recession. According to the WHO Global Oral Health Status Report 2022, approximately 2 billion people have dental caries, whereas 514 million children with primary teeth suffer from tooth decay.
The rapidly expanding population and the consequently increasing burden of periodontal diseases, and oral cancers is expected to positively influence the expansion of the dental caries treatment industry. As per WHO, the population aged 60 years and above across the globe will double to 2.1 billion by 2050. It has also been estimated that the number of people aged 80 years and above will reach 426 million by 2050, accounting for thrice the size in 2020.
Additionally, the increasing number of geriatric individuals worldwide is estimated to boost the need for advanced oral care. Dental complications can also be touted as the most common signs as well as causes of aging. Lack of awareness regarding dental care, and inaccessibility issues in underdeveloped regions pertaining to dental services will indicate a lucrative scope for the expansion of the dental caries industry.
The COVID-19 pandemic, however, had a negative impact on the analytical and treatment processes for dental caries. Dental surgeons were at high risk of contracting the virus due to direct exposure during dental treatments. Moreover, the cancellation of non-essential dental procedures due to an increasing number of patients infected with COVID-19 hampered the industry outlook.
Dental caries treatment market from vaccines segment is predicted to register substantial revenue gains by 2032. The growth can be attributed to the increasing use of vaccines to prevent dental caries. Extensive R&D activities in the past decade has helped prevent dental carries through local passive immunization using transgenic plant antibodies, murine monoclonal antibodies, and egg-yolk antibodies, subsequently favoring the industry growth.
In terms of end-use, the dental clinics segment is estimated to account for a significant share of the dental caries treatment market over 2032. Dental clinics have high patient preference since they offer access to comprehensive care with effective diagnosis and medical professionals. Rising cases of oral diseases are also fueling patient visits across dental clinics. As per the Centers for Disease Control & Prevention (CDC), more than 45% of all adults above the age of 30 experience symptoms of gum disease due to nutrient deficiencies.
North America dental caries treatment market size is expected to expand significantly from 2023-2032. Increasing awareness regarding oral hygiene and the surging geriatric population are some of the primary factors propelling the demand for dental care products and services. The region has also witnessed a notable rise in the prevalence of oral cancers. For instance, the American Cancer Society estimates 54,000 new cases of oropharyngeal cancer or oral cavity in the year 2022.
Some of the leading companies in the dental caries treatment market include Abbott Laboratories, Sanofi, Bayer, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca, Merck & Co, Novartis, and 3M Company. These market players are focusing on new product launches, collaborations, and acquisitions for better market presence.